SOURCE: Xtalks

Xtalks Webinars

January 12, 2015 07:05 ET

Oral Oncology Therapies: Meeting New Patient Adherence Challenges, New Webinar Hosted by Xtalks

TORONTO, ON--(Marketwired - January 12, 2015) - This webinar aims to address oral oncology adherence challenges and how to overcome them. The live broadcast takes place on Tuesday, January 27, 2015 at 11am EST (4pm GMT).

The speakers will discuss proven approaches to address these challenges through patient and caregiver engagement with the help of qualified oncology nurse educators, MSL's and even specialized pharmaceutical reps engaging providers. This multi-team focused approach can be highly beneficial to the patients. Strategies employed specifically by the oncology nurse educators include tailored, flexible, customer based focus, comprehensive patient education regarding dosing, disease recurrence with non-medication adherence, identification and resolution of barriers to compliance all these as part of an individualized therapeutic plan.

According to PhRMA's 2012 Medicines in Development Report, more than 1,000 cancer agents are now being pursued by biopharmaceutical researchers -- And among these new approaches in the fight against cancer are oral oncolytics.

An increasing proportion of all antineoplastic agents in today's pipeline are being developed as oral drugs. Although oral chemotherapy has existed for decades, oral oncolytics are becoming a more popular therapeutic option than intravenous (IV) chemotherapy for a number of cancers. In addition to providing patients with a more convenient form of administration, many of these new agents target specific biologic processes in cancer cells and exhibit a higher degree of safety and effectiveness compared to traditional chemotherapies, which usually indiscriminately attack both cancer and healthy cells.

This is good news for oncologists and their patients; however, it comes with its own set of challenges, namely patient access and adherence.

This is because a significant part of the responsibility in managing drug regimens and monitoring for dosing/toxicity is shifted from the oncology team to the patient and/or caregiver. For some patients, having this level of direct involvement in their disease management and treatment may be empowering, while for others, this shift in responsibility can be overwhelming, especially if the appropriate family and/or caregiver support is not in place.

Join the panel including Susie Newton, Senior Director of Health Management Solutions at Quintiles, Cheryl Fowler, National Director at Hematology Clinical Nurse Educators, and Nicole Korak, National Director at Oncology Clinical Nurse Educators, for an informative session. Specific case studies will be cited and a live Q&A with the audience will take place at the end of the main presentation.

To learn more about this event visit: Oral Oncology Therapies: Meeting New Patient Adherence Challenges

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/sponsorship.ashx

Image Available: http://www.marketwire.com/library/MwGo/2015/1/9/11G029982/Images/quintiles_logo_x_200-887496335075.jpg

Contact Information